Perfect Medical Health Management Limited (1830.HK)
HKD 2.21
(-1.34%)
HKD 2.21
(-1.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 499.67 Million | 560.55 Million | 516.7 Million | 605.91 Million | 645.43 Million | 453.41 Million |
| Net Income | 315.8 Million | 315.63 Million | 305.24 Million | 284.63 Million | 360.15 Million | 319.03 Million |
| Depreciation & Amortization | 201.96 Million | 223.59 Million | 219.04 Million | 171.25 Million | 154.82 Million | 70.39 Million |
| Deferred income taxes | - | -460.83 Million | -416.82 Million | -342.98 Million | -233.9 Million | -14.64 Million |
| Stock-based compensation | 1.3 Million | 4.23 Million | 4.58 Million | 3.11 Million | 1.01 Million | 3.14 Million |
| Change in working capital | -14.49 Million | 9.65 Million | -73.69 Million | 152.14 Million | 121.9 Million | 11.5 Million |
| Other non-cash items | 400.97 Million | 468.26 Million | 478.35 Million | 337.74 Million | 241.43 Million | 63.99 Million |
| Investing Cash Flow | 165.28 Million | -222.5 Million | 8.05 Million | -300.82 Million | -75.21 Million | -94.73 Million |
| Investments in PPE | -54.17 Million | -26.74 Million | -144.55 Million | -78.22 Million | -96.43 Million | -53.17 Million |
| Acquisitions | 4.84 Million | 247 Thousand | 1.59 Million | 1.89 Million | 3.99 Million | 17.48 Million |
| Investment purchases | - | -210 Million | -233.5 Million | -720.55 Million | -103.76 Million | -73.48 Million |
| Sales/Maturities of investments | 218.72 Million | 16.29 Million | 385.38 Million | 496.85 Million | 121.94 Million | 16.15 Million |
| Other Investing Activities | -4.1 Million | -2.3 Million | -864 Thousand | -788 Thousand | -953 Thousand | -1.71 Million |
| Financing Cash Flow | -525.66 Million | -335.01 Million | -565.97 Million | -394.41 Million | -330.45 Million | -307.13 Million |
| Debt repayment | -121.11 Million | -135.68 Million | -137.72 Million | -109.49 Million | -87.79 Million | - |
| Dividends payments | -391.93 Million | -191.78 Million | -405.48 Million | -282.27 Million | -218.76 Million | -327.12 Million |
| Common Stock Repurchased | -1.39 Million | -10.02 Million | -21.66 Million | -4.48 Million | -41.95 Million | - |
| Common Stock Issuance | - | 14.99 Million | 14.99 Million | 14.98 Million | 29.96 Million | 19.98 Million |
| Other Financing Activities | 4.69 Million | -12.52 Million | -16.09 Million | -13.14 Million | -11.89 Million | -55.25 Million |
| Accounts receivables | -13.14 Million | -23.7 Million | 63.2 Million | -3.19 Million | 78.75 Million | 12.14 Million |
| Accounts payables | 10.04 Million | 17.33 Million | -34.29 Million | 6.84 Million | -2.84 Million | -2.89 Million |
| Inventory | 2.46 Million | -3.03 Million | -3.06 Million | -1 Million | 855 Thousand | -643 Thousand |
| Other working capital | -13.85 Million | 19.05 Million | -99.54 Million | 149.5 Million | 45.14 Million | 2.89 Million |
| Cash at beginning of period | 446.62 Million | 454.15 Million | 498.57 Million | 566.45 Million | 342.69 Million | 299.41 Million |
| Cash at end of period | 575.27 Million | 446.62 Million | 454.15 Million | 498.57 Million | 566.45 Million | 338.67 Million |
| Capital Expenditure | -54.17 Million | -26.74 Million | -144.55 Million | -78.22 Million | -96.43 Million | -53.17 Million |
| Effect of forex changes on cash | -10.5 Million | -9.89 Million | -3.17 Million | 20.97 Million | -15.91 Million | -12.28 Million |
| Net cash flow / Change in cash | 128.64 Million | -7.52 Million | -44.42 Million | -67.87 Million | 223.76 Million | 39.26 Million |
| Free Cash Flow | 445.49 Million | 533.81 Million | 372.15 Million | 527.68 Million | 549 Million | 400.24 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 315.8 Million | 149.4 Million | 166.39 Million | 164.98 Million | 315.63 Million | 150.65 Million |
| Depreciation & Amortization | 201.96 Million | 99.28 Million | 102.67 Million | 109.47 Million | 223.59 Million | 114.11 Million |
| Deferred income taxes | - | - | - | - | -460.83 Million | - |
| Stock-based compensation | 1.3 Million | 1.3 Million | - | - | 4.23 Million | 4.23 Million |
| Change in working capital | -14.49 Million | -35.39 Million | - | -25.27 Million | 9.65 Million | - |
| Other non-cash items | 400.97 Million | -5.5 Million | 224.31 Million | 206.21 Million | 468.26 Million | 262.28 Million |
| Investing Cash Flow | 165.28 Million | -25.72 Million | 188.29 Million | -152.46 Million | -222.5 Million | -70.04 Million |
| Investments in PPE | -54.17 Million | -54.17 Million | - | -26.74 Million | -26.74 Million | - |
| Acquisitions | 4.84 Million | - | - | - | 247 Thousand | - |
| Investment purchases | - | - | - | - | -210 Million | - |
| Sales/Maturities of investments | 218.72 Million | - | - | - | 16.29 Million | - |
| Other Investing Activities | -4.1 Million | 28.45 Million | 188.29 Million | -124.27 Million | -2.3 Million | -70.04 Million |
| Financing Cash Flow | -525.66 Million | -242.57 Million | -278.4 Million | -240.67 Million | -335.01 Million | -94.34 Million |
| Debt repayment | -121.11 Million | - | -57.75 Million | - | -135.68 Million | -70.26 Million |
| Dividends payments | -391.93 Million | -391.93 Million | - | -191.78 Million | -191.78 Million | - |
| Common Stock Repurchased | -1.39 Million | -1.39 Million | - | -10.02 Million | -10.02 Million | - |
| Common Stock Issuance | - | - | - | - | 14.99 Million | - |
| Other Financing Activities | 4.69 Million | 150.75 Million | -220.64 Million | -38.86 Million | -12.52 Million | -24.08 Million |
| Accounts receivables | -13.14 Million | -13.14 Million | - | -34.98 Million | -23.7 Million | - |
| Accounts payables | 10.04 Million | - | - | - | 17.33 Million | - |
| Inventory | 2.46 Million | 2.46 Million | - | -3.03 Million | -3.03 Million | - |
| Other working capital | -13.85 Million | -24.71 Million | - | 12.74 Million | 19.05 Million | - |
| Cash at beginning of period | 446.62 Million | 624.51 Million | 446.62 Million | 573.57 Million | 454.15 Million | 454.15 Million |
| Cash at end of period | 575.27 Million | 575.27 Million | 632.29 Million | 446.62 Million | 446.62 Million | 573.57 Million |
| Capital Expenditure | -54.17 Million | -54.17 Million | - | -26.74 Million | -26.74 Million | - |
| Effect of forex changes on cash | -10.5 Million | 2.08 Million | -12.59 Million | 3.36 Million | -9.89 Million | -13.26 Million |
| Net cash flow / Change in cash | 128.64 Million | -49.23 Million | 185.66 Million | -126.94 Million | -7.52 Million | 119.41 Million |
| Free Cash Flow | 445.49 Million | 154.92 Million | 288.02 Million | 234.97 Million | 533.81 Million | 298.83 Million |
MASS
TFG
MNFSF
450080
0547
SCHAND